bibliographic entry 10166892 [be/10166892]
https://w3id.org/oc/corpus/be/10166892

is a
content
  • Russell‐Jones D, Cuddihy RM, Hanefeld M et al. Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug‐naive patients with type 2 diabetes (DURATION‐4): a 26‐week double‐blind study. Diabetes Care 2012; 35: 252–258. PMID: 22210563
references